The same GLP-1 medications reshaping weight loss have been linked to lower rates of depression and anxiety, adding to a ...

This discovery may “support a more comprehensive approach to menopause care,” according to one doctor. It feels like there’s ...

-- Reposted from the online magazine, "The Trauma & Mental Health Report" The pharmaceutical industry grosses over $300 billion a year in psychotropic medication sales. Included in this figure are ...

About 1 in 5 women will experience depression and anxiety during pregnancy or in the year after giving birth. If untreated, a ...

Previous reports suggest GLP-1 medications prescribed to treat obesity, such as Wegovy, may cause adverse mental health events, including depression or thoughts of suicide. However, additional ...

Depression is a mental illness that can make everyday tasks feel difficult. But health professionals can offer many tools to help keep symptoms at bay. Depression, also referred to as major depressive ...

BOSTON (Reuters) - Targacept Inc, a small drugmaker that began life inside the bowels of R.J. Reynolds Tobacco Co, has for years been using its understanding of nicotine to develop experimental ...

Anti-inflammatory medications reduce depressive symptom severity and anhedonia in individuals with depression and elevated levels of inflammation, according to a new study published in the American ...

For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major depressive disorder. Early studies suggested promise, but enthusiasm faded after ...

This story was reviewed by Daniel Z. Lieberman, MD. Maybe you're neck-deep in a two-week funk you just can't seem to shake, or perhaps you've been struggling with severe depression for years. No ...

Vertex makes its largest-ever deal, skyrocketing health insurance costs, and more biotech news from The Readout ...

Sage shares surge over 35% after acquisition announcement Supernus to save up to $200 million annually from shared expenses Deal expected to close in Q3 2025, accretive by 2026 The deal will help ...